A method is provided for controlling the molecular weight of a polyhydroxyalkanoate containing at least one of a unit: --[OCH((CH.sub.2).sub.m R.sub.1)CH.sub.2 C(O)]-- (m=1-8; R.sub.1 is a residue having a ring structure of any of phenyl and thienyl structure), and a unit: --[OCH((CH.sub.2).sub.k C.sub.6 H.sub.1) R.sub.2)CH.sub.2 C(O)]-- (k=0-8; R.sub.2 denotes a substituent on the cyclohexyl group including H, CN, NO.sub.2, halogen atom, CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, CF.sub.3, C.sub.2 F.sub.5 or C.sub.3 F.sub.7), wherein a microorganism is cultivated in the presence of a hydroxyl group-containing compound, which is capable of producing the polyhydroxyalkanoate from R.sub.3 (CH.sub.2).sub.q CH.sub.2 CH.sub.2 COOH (q=1-8; R.sub.3 contains a residue having a ring structure of phenyl or thienyl) or R.sub.4 C.sub.6 H.sub.10 (CH.sub.2).sub.r CH.sub.2 CH.sub.2 COOH (r=0-8; R.sub.4 denotes a substituent on the cyclohexyl group including H, CN, NO.sub.2, halogen, CH.sub.3, C.sub.2 H.sub.5, C.sub.3 H.sub.7, CF.sub.3, C.sub.2 F.sub.5, or C.sub.3 F.sub.7).

 
Web www.patentalert.com

< Pharmaceutical compositions comprising TGF-beta

< Amphipathic aldehydes and their uses as adjuvants and immunoeffectors

> Methods and compositions for poly-.beta.-1-4-N-acetylglucosamine cell therapy system

> Compositions and methods for treating bone deficit conditions

~ 00091